DCT

3:17-cv-08825

Boehringer Ingelheim Pharma Inc v. Sandoz Inc

General
Filed
10/20/17
Cause of ActionInfringement
SectorBiotech
Status
Closed (08/04/21)
Patent Owner
NPE (W)
Judge
Period
PO Win Rate
--
74%